Lipid lowering potential of combined phytosterols and long chain omega-3 fatty acids

Phytosterols and omega-3 fatty acids for alleviation of plasma lipids in participants with Hyperlipidaemia

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12606000453583

Acronym

POFA Trial

Enrollment

Registered

2006-10-20

Start date

2007-02-14

Completion date

2008-11-28

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

No change required, the details have already been provided.

Interventions

Participants are randomised to recieve either 4g omega-3 fish oil capsules or 25g plant sterol spread + 4g fish oil capsules for 3 weeks for the treatment. Participants are assessed at baseline and again at the completion of the study (3 weeks)

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

35 Years to 70 Years

Healthy volunteers

Inclusion criteria

Participants with hyperlipidemia, and are not taking any lipid-lowering medications.

Exclusion criteria

Subjects already taking fish oil supplements and/or regularly consuming phytosterol enriched fat spreads.

Outcome results